Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Production of ELOVL4 Transgenic Pigs: An Animal Model for Stargardt–Like Macular Degeneration

J.L. Estrada; J.R. Sommer; B.E. Collins; C.A. Alexander; B. Mir; Y. Chen; K.A. Howes; J.A. Piedrahita; K. Zhang; R.M. Petters

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5814.

ARVO Annual Meeting Abstract May 2006

Enhanced AGE–R2 Immunoreactivity Associated with Aging Pathology in Human Donor Eyes

K.A. Howes; C. Gerstner; K. Zhang; C. Hunter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):868.

ARVO Annual Meeting Abstract May 2005

Effects of S100B, Amphoterin and RAGE on RPE Differentiation in the Murine Eye

C.M. Hunter; C. Gerstner; A. Marks; C. Legraverend; K.A. Howes

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5285.

ARVO Annual Meeting Abstract May 2005

S100B, Amphoterin, and RAGE in ARPE–19 Cell Differentiation

C.D. Gerstner; C.M. Hunter; K.A. Howes

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5286.

ARVO Annual Meeting Abstract May 2005

AGE Products and S100B Induce RAGE–Mediated Alterations in Expression of Proteins Implicated in AMD Pathogenesis.

K.A. Howes; C. Gerstner; C. Hunter

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5287.

ARVO Annual Meeting Abstract May 2004

AGE (Advanced glycation end products) receptors in age–related macular degeneration

K.A. Howes; Y. Liu; J.M. Frederick; W. Baehr

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2286.

ARVO Annual Meeting Abstract May 2003

Induction of Age-related Macular Degeneration (AMD) by Advanced Glycation End (AGE) Products and S100B

K.A. Howes; Y. Sauvé; N. Roychowdhury; A. Marks; J.M. Frederick; W. Baehr

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1728.

Advertisement